Form 4 for AGL agilon health, inc.
Accepted 2023-06-26 00:00:00 ET · period of report 2023-06-22 · accession 0001019056-23-000289 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-26 | 2023-06-22 | AGL | Battaglia Silvana | Dir | A - Grant | $0.00 | +8,963 | 8,963 | New | $0 |
| D | 2023-06-26 | 2023-06-22 | AGL | Battaglia Silvana | Dir | A - Grant | $0.00 | +19.3K | 19.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-22 | A | A | 8,963 | $0.00 | 8,963 | D | — | — | (F1) This grant of restricted stock units under the agilon health, inc. 2021 Omnibus Equity Incentive Plan (the "Plan") will vest in full on June 22, 2024, subject to the reporting person's continued service as a director. (F2) Includes restricted stock units. |
| 2 | Derivative | Options (Right to buy) | 2023-06-22 | A | A | 19,251 | $0.00 | 19,251 | D | $16.74 · — to 2033-06-22 | 19,251 Common Stock | (F3) This option grant under the Plan will become exercisable in three equal installments on each anniversary of the grant date, commencing on June 22, 2024, subject to the reporting person's continued service as a director. |